21.20
-0.60
(-2.75%)
As of 1:18:00 PM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Tobias Larsson Agervald | Chief Executive Officer | 4.84M | -- | 1976 |
| Ms. Karin Botha | Chief Financial Officer | -- | -- | 1973 |
| Mr. Magnus Gram | C.S.O | -- | -- | 1980 |
| Mr. Peter Gilmour Ph.D. | Head of Preclinical Science | -- | -- | 1970 |
| Ms. Sara Thuresson | Head of Clinical Operations | -- | -- | 1976 |
| Dr. Michael Reusch | Chief Medical Officer | -- | -- | 1960 |
| Mr. Torbjorn Larsson | Head of Chemistry, Manufacturing & Controls | -- | -- | 1960 |
Guard Therapeutics International AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 11
Description
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
Corporate Governance
Guard Therapeutics International AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 20, 2025 at 10:59 AM UTC
Guard Therapeutics International AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
PHAL.ST PharmaLundensis AB
1.0300
-8.04%
SIMRIS-B.ST Simris Group AB (PUBL)
0.0796
-7.87%
COMBI.ST CombiGene AB (publ)
2.3400
-3.31%
CRNA.OL Circio Holding ASA
0.6940
-1.70%
2CUREX.ST 2cureX AB (publ)
0.4400
+22.22%
CMOTEC-B.ST Scandinavian ChemoTech AB (publ)
1.1200
+1.82%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4700
-3.09%
QUIA.ST Quia Pharma AB (publ)
0.0082
-7.87%
ULTI.OL Ultimovacs ASA
2.1850
+0.69%
NANECH.ST NanoEcho AB
0.1220
-30.05%